Research at Boston Medical Center
At Boston Medical Center, research efforts are imperative in allowing us to provide our patients with quality care. Read more about our ongoing research and clinical trials.
Grayken Study First to Link Opioid Pharmaceutical Marketing to Overdose Deaths
Bristol-Myers Squibb and BMC Announce Research Collaboration to Investigate Markers of Immuno-Oncology Response and Resistance
Urine Drug Testing May Be Important in Early Phases of Addiction Treatment
$116 Million
Sponsored Funding in FY2017
581 Projects
by 228 Principal Investigators
157,880 Sq. Ft.
Bench & Clinical Research Space
Medications Could Fill Treatment Gap for Adolescents with Obesity
Pediatric obesity medicine and surgery specialists outline an urgent need for evidence-based guidance on the use of obesity pharmacotherapy.
Investigators Close In on Best Treatment Guidelines for Critical Limb Ischemia
A new report chronicles a randomized controlled trial that seeks to compare treatment efficacy, functional outcomes, cost effectiveness, and quality of life for 2,100 patients suffering from the condition.
Improved Maternity Care Practices Decrease Racial Gaps in Breastfeeding in the U.S. South
A new paper links successful implementation of Baby-Friendly™ practices in the southern U.S. with increases in breastfeeding rates.
Targeted Hepatitis C Testing Misses Substantial Number of Cases in Correctional Setting
A study led by BMC found routine Hepatitis C testing identified a significant number of cases that would have been missed by targeted testing among a population of individuals in prisons.
In the News (Media)
BEST-CLI Trial Examining Critical Limb Ischemia
Jan. 23, 2019
More Money Spent Marketing Opioids, More Overdose Deaths Followed
Jan. 18, 2019
Study Links Opioid Epidemic to Painkiller Marketing
Jan. 18, 2019
Drug Testing Early in Treatment Can Enhance Care
Jan. 17, 2019
